Event Detail
Title 
New Understanding of Hemostasis (COBM Panel) -The Balance Between Bleeding and Clotting  
Presenter  Waters, Jonathan H. *
Shander, Aryeh *
Grigore, Alina M. **
Tanaka, Kenichi *
Date and Time  Saturday, October 17, 2009 11:00AM - 12:30PM
Location(s)  Morial Convention Center
Room 244
Category  Luncheon Panels
Learning Track  Cardiac Anesthesia (CA)
FeeCode  LP02
FeeCode Description  New Understanding of Hemostasis (COBM Panel) -The Balance Between Bleeding and Clotting
Price  $50.00
Objective  At the conclusion of the session, the participant will: 1) Have an understanding of the complex interplay between hyper and hypo-coagulable states; 2) Be able to describe the new drugs and clotting factor preparations that may be used to treat the hemostatic imbalance in the severely bleeding patient.Genetic influences on hypercoagulability will be discussed. Risk of bleeding and the cost of transfusion will also be covered for the bleeding surgical patient.
Description 1 
Description 2 
Disclosure  Waters, Jonathan H. *
This speaker has indicated that he or she does have a significant financial relationship with the manufacturer of a commercial product or provider of a commercial service that may be discussed in this presentation. The presenter will describe that relationship before beginning the presentation.

Biotronics, Inc - Salary;
Shander, Aryeh *
This speaker has indicated that he or she does have a significant financial relationship with the manufacturer of a commercial product or provider of a commercial service that may be discussed in this presentation. The presenter will describe that relationship before beginning the presentation.

Bayer - Consulting Fees - Honoraria; Biopure - Consulting Fees; NovoNordisk - Consulting Fees - Honoraria; OrthoBiotech - Funded Research - Consulting Fees - Honoraria; Zymogenetics - Funded Research - Consulting Fees - Honoraria; Novartis - Consulting Fees; Abbott - Funded Research; AstraZeneca - Funded Research; Baxter - Honoraria; Pfizer - Honoraria;
Grigore, Alina M. **
This speaker has indicated that he or she has no significant financial relationship with the manufacturer of a commercial product or provider of a commercial service that may be discussed in this presentation.

Tanaka, Kenichi *
This speaker has indicated that he or she does have a significant financial relationship with the manufacturer of a commercial product or provider of a commercial service that may be discussed in this presentation. The presenter will describe that relationship before beginning the presentation.

CSL Behring - Funded Research - Consulting Fees;